(Q67914546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848881%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848881%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

9 December 2022

author name string

L. Nässberger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848881

9 December 2022

A. C. Johansson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848881

9 December 2022

S. Björck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848881

9 December 2022

A. G. Sjöholm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848881

9 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1848881

9 December 2022

publication date

1 March 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848881%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2796.1991.tb00342.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2796.1991.tb00342.x/fullpdf

9 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Journal of Internal Medicine

9 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848881%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848881%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848881%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

261-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848881%20AND%20SRC:MED&resulttype=core&format=json

Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects

9 December 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

9 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Rapidly progressive glomerulonephritis after hydralazine

9 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Hydralazine and lupus nephritis

9 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Severe renal failure in hydralazine-induced lupus

9 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Rapidly progressive nephritis in patients taking hydralazine

9 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Circulating anti-neutrophil cytoplasm antibodies in patients with rapidly progressive glomerulonephritis and extracapillary proliferation

9 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Antimyeloperoxidase antibodies in patients with extracapillary glomerulonephritis

9 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique

9 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Myeloperoxidase-Mediated Iodination in Granulocytes

9 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Isolation and properties of human neutrophil myeloperoxidase

9 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Procainamide-lymphocyte reactions. a possible explanation for drug-induced autoimmunity

9 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype

9 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

9 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Antibodies to components of neutrophil cytoplasm: a new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis

9 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Circulating anti-elastase in systemic lupus erythematosus

9 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Focal glomerulonephritis in the course of hydralazine-induced lupus syndrome

9 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

Possible mechanisms of the hydralazine‐related lupus‐like syndrome

9 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1991.TB00342.X

9 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848881%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference